Bartlett & Co’s Teva Pharmaceuticals TEVA Stock Holding History

Bartlett & Co’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$11K	Buy	1,094 +594	+119%	+$5.55K	﹤0.01%	991
2023 Q3	$5K	Hold	500	–	–	﹤0.01%	999
2023 Q2	$4K	Hold	500	–	–	﹤0.01%	1018
2023 Q1	$4K	Hold	500	–	–	﹤0.01%	935
2022 Q4	$5K	Hold	500	–	–	﹤0.01%	928
2022 Q3	$4K	Hold	500	–	–	﹤0.01%	970
2022 Q2	$4K	Hold	500	–	–	﹤0.01%	1081
2022 Q1	$5K	Buy	+500	New	+$4.17K	﹤0.01%	923
2021 Q4	–	Sell	-500	Closed	-$5K	–	839
2021 Q3	$5K	Hold	500	–	–	﹤0.01%	774
2021 Q2	$5K	Hold	500	–	–	﹤0.01%	764
2021 Q1	$6K	Hold	500	–	–	﹤0.01%	778
2020 Q4	$5K	Hold	500	–	–	﹤0.01%	798
2020 Q3	$5K	Hold	500	–	–	﹤0.01%	739
2020 Q2	$6K	Sell	500 -65	-12%	-$735	﹤0.01%	726
2020 Q1	$5K	Buy	+565	New	+$5.79K	﹤0.01%	725
2019 Q3	$4K	Hold	565	–	–	﹤0.01%	795
2019 Q2	$5K	Hold	565	–	–	﹤0.01%	631
2019 Q1	$9K	Hold	565	–	–	﹤0.01%	589
2018 Q4	$9K	Hold	565	–	–	﹤0.01%	589
2018 Q3	$12K	Hold	565	–	–	﹤0.01%	591
2018 Q2	$14K	Buy	565 +500	+769%	+$10.2K	﹤0.01%	570
2018 Q1	$1K	Hold	65	–	–	﹤0.01%	717
2017 Q4	$1K	Sell	65 -20	-24%	-$301	﹤0.01%	683
2017 Q3	$1K	Hold	85	–	–	﹤0.01%	669
2017 Q2	$3K	Sell	85 -1,452	-94%	-$44.9K	﹤0.01%	647
2017 Q1	$49K	Hold	1,537	–	–	﹤0.01%	434
2016 Q4	$56K	Sell	1,537 -2,145	-58%	-$85.6K	﹤0.01%	413
2016 Q3	$169K	Sell	3,682 -844	-19%	-$44K	0.01%	260
2016 Q2	$227K	Buy	4,526 +559	+14%	+$29.8K	0.01%	242
2016 Q1	$212K	Hold	3,967	–	–	0.01%	243
2015 Q4	$260K	Sell	3,967 -70	-2%	-$4.33K	0.01%	228
2015 Q3	$228K	Sell	4,037 -1	-0%	-$65	0.01%	235
2015 Q2	$239K	Sell	4,038 -949	-19%	-$58.5K	0.01%	236
2015 Q1	$311K	Buy	4,987 +950	+24%	+$55.2K	0.02%	223
2014 Q4	$232K	Hold	4,037	–	–	0.01%	239
2014 Q3	$217K	Sell	4,037 -25	-0.6%	-$1.32K	0.01%	245
2014 Q2	$213K	Hold	4,062	–	–	0.01%	249
2014 Q1	$215K	Sell	4,062 -235	-5%	-$10.9K	0.01%	249
2013 Q4	$172K	Sell	4,297 -289	-6%	-$11.4K	0.01%	262
2013 Q3	$173K	Sell	4,586 -1,700	-27%	-$66.3K	0.01%	254
2013 Q2	$246K	Buy	+6,286	New	+$245K	0.01%	236

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Bartlett & Co's TEVA Position: Q4 2023 in Review

Bartlett & Co increased its Teva Pharmaceuticals (TEVA) stake by 119% in Q4 2023, buying an estimated $5.55K and bringing the position to 1,094 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #991.

Bartlett & Co first reported a position in TEVA in Q2 2013 and has held it in 41 quarters since. The position peaked at $311K in Q1 2015. 447 funds tracked by Wall St. Rank hold TEVA as of Q4 2023.

Bartlett & Co held 1,094 shares of Teva Pharmaceuticals worth $11K as of Q4 2023.
Bartlett & Co bought 594 Teva Pharmaceuticals shares in Q4 2023, an estimated $5.55K.
Teva Pharmaceuticals made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #991 holding.
Bartlett & Co first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 41 quarters since.
Bartlett & Co's Teva Pharmaceuticals position peaked at $311K in Q1 2015.
447 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.